Skip to content

Analgesic effect of methylene blue combined with ropivacaine after ilium grafting at alveolar cleft

Analgesic effect of methylene blue combined with ropivacaine after ilium grafting at alveolar cleft

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080483
Enrollment
Unknown
Registered
2024-01-30
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cleft alveolar

Interventions

experimental group:1ml methylene blue injection and 10ml ropivacaine was injected into the incision
control group:10ml ropivacaine was injected into the incision

Sponsors

Plastic Surgery Hospital,Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Obvious alveolar cleft was diagnosed before surgery 2. Normal communication ability, able to complete VAS score independently, no mental illness 3. No aspirin or related analgesics were taken within 2 weeks before surgery 4. The patient and his guardian voluntarily choose autogenous iliac crest repair surgery, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with postoperative analgesia pump were selected 2. Patients with allergies or allergies to materials, reagents and drugs related to disease treatment 3. Patients dependent on alcohol or other addictive drugs 4. Incomplete data collection and loss may affect patients who are evaluated for study results 5. Patients who are participating in other clinical trials and have not reached the end point

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
Consumption of analgesic 24h,48h after surgery;The duration of claudication;

Countries

China

Contacts

Public ContactSong Tao

Plastic Surgery Hospital,Chinese Academy of Medical Sciences

songtao@psh.pumc.edu.cn+86 135 8153 7740

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026